• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
Back

Corporate News

Akums Drugs receives compliance certificate from MUFG Intime India for Q3 2026
09-Oct-2026, 07:04

Akums Drugs and Pharmaceuticals Limited informed the National Stock Exchange of India Ltd. and BSE Limited that it has received a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.